Mycobacterium abscessus is the most drug-resistant mycobac-terial species. Combination therapy with intravenous amikacin plus cefoxitin or imipenem and an oral macrolide for 2 to 4 months is recommended. Recently, M. abscessus was split into M. abscessus sensu stricto, Mycobacterium massiliense, and My-cobacterium bolletii. Effective therapy for M. massiliense lung disease remains elusive but still usually requires parenteral agents. We report a case of M. massiliense lung disease that was treated successfully with oral antibiotics only.
展开▼